IRIS
DE LUCA, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.038
NA - Nord America 2.778
EU - Europa 2.275
SA - Sud America 347
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 8.519
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.675
SG - Singapore 1.275
RU - Federazione Russa 1.012
VN - Vietnam 594
IT - Italia 557
CN - Cina 549
BR - Brasile 276
HK - Hong Kong 258
DE - Germania 162
FR - Francia 99
NL - Olanda 94
GB - Regno Unito 77
IN - India 77
BD - Bangladesh 74
FI - Finlandia 70
CA - Canada 47
JP - Giappone 44
KR - Corea 38
MX - Messico 36
ES - Italia 34
AR - Argentina 30
UA - Ucraina 29
PL - Polonia 26
IE - Irlanda 25
GR - Grecia 18
CI - Costa d'Avorio 17
ZA - Sudafrica 17
PH - Filippine 16
TH - Thailandia 15
IQ - Iraq 13
SE - Svezia 13
EC - Ecuador 12
ID - Indonesia 10
LT - Lituania 10
PK - Pakistan 10
TR - Turchia 9
TW - Taiwan 9
AT - Austria 8
CO - Colombia 7
JO - Giordania 7
CL - Cile 6
EG - Egitto 6
JM - Giamaica 6
MA - Marocco 6
MY - Malesia 6
PY - Paraguay 6
AL - Albania 5
DZ - Algeria 5
SA - Arabia Saudita 5
TN - Tunisia 5
UZ - Uzbekistan 5
VE - Venezuela 5
AU - Australia 4
BE - Belgio 4
CZ - Repubblica Ceca 4
KE - Kenya 4
PE - Perù 4
RO - Romania 4
SY - Repubblica araba siriana 4
BG - Bulgaria 3
CR - Costa Rica 3
ET - Etiopia 3
KZ - Kazakistan 3
AD - Andorra 2
AE - Emirati Arabi Uniti 2
BN - Brunei Darussalam 2
CH - Svizzera 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
LV - Lettonia 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
Totale 8.508
Salva come PNG Salva come JPEG
Città #
Singapore 619
San Jose 586
Chandler 257
Ashburn 249
Hong Kong 249
Moscow 239
Beijing 171
Ho Chi Minh City 170
Hanoi 120
Hefei 119
Naples 104
Los Angeles 84
Santa Clara 79
Munich 69
Lauterbourg 67
Millbury 61
Napoli 57
The Dalles 55
Amsterdam 47
Des Moines 40
New York 38
Tokyo 37
São Paulo 36
Lawrence 35
Redondo Beach 35
Boston 31
Council Bluffs 30
Helsinki 30
Buffalo 27
Haiphong 27
Milan 27
Orem 27
Dallas 26
Rome 25
Seoul 25
Da Nang 22
Kochi 21
Falkenstein 20
Frankfurt am Main 20
Warsaw 20
Wilmington 20
Atlanta 19
Princeton 19
Montreal 17
Valencia 17
Biên Hòa 16
London 16
Nanjing 16
Chicago 15
Seattle 15
Turku 15
Heraklion 14
Chennai 13
Brooklyn 12
Denver 12
Rio de Janeiro 12
Casalnuovo di Napoli 11
Fairfield 11
Johannesburg 11
Nanchang 11
Dublin 10
Houston 10
Mexico City 10
Stockholm 10
Toronto 10
Can Tho 9
Nuremberg 9
Baghdad 8
Dong Ket 8
Guangzhou 8
Hải Dương 8
San Francisco 8
Ankara 7
Belo Horizonte 7
Lappeenranta 7
Phoenix 7
Salerno 7
Amman 6
Bologna 6
Hebei 6
Monterrey 6
Mumbai 6
Poplar 6
Buenos Aires 5
Cairo 5
Campinas 5
Düsseldorf 5
Manchester 5
Memphis 5
Messina 5
Newark 5
Ottawa 5
Piscataway 5
Portici 5
Salvador 5
Santa Maria 5
Tashkent 5
Thái Nguyên 5
Tân Tiến 5
Woodbridge 5
Totale 4.557
Salva come PNG Salva come JPEG
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 223
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 188
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 166
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 165
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 161
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 157
Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer 156
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 155
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 154
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 149
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 149
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 148
Ciliated foregut cyst of the pancreas: A benign lesion with elevated CEA levels 147
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 143
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 142
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 140
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 138
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 136
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 136
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx 136
A challenging case of enteric-type lung adenocarcinoma metastatic to the thyroid harboring RET-fusion diagnosed on fine-needle aspiration 135
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 135
Immunohistochemical Nuclear Expression of β-Catenin as a Surrogate of CTNNB1 Exon 3 Mutation in Endometrial Cancer 133
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 133
Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study 130
Predictive molecular pathology in the time of COVID-19 130
Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study 128
Methods for actionable gene fusion detection in lung cancer: now and in the future 128
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE 127
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 127
EGFR mutation detection by microfluidic technology: a validation study. 126
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel 126
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 124
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 121
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test 121
Tumor mutational burden on cytological samples: A pilot study 120
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 120
How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases: Insights from the International Molecular Cytopathology Meeting 118
Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates 118
Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm 118
KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs, and beyond 117
EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer 117
PD-L1 and beyond: Immuno-oncology in cytopathology 117
A narrative review of predictive immuno-histo/cyto chemistry in lung cancer: focus on gene fusions and PD-L1 expression 116
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 116
KRAS mutation detection by high resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer 114
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review 113
EGFR analysis: Current evidence and future directions 111
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 111
Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature 105
Diagnostic accuracy of p53 immunohistochemistry as surrogate of TP53 sequencing in endometrial cancer 105
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice 102
Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018 100
Concomitant Rare KRAS and BRAF Mutations in Lung Adenocarcinoma: A Case Report 100
Molecular testing in salivary gland cytopathology: A practical overview in conjunction with the Milan system 99
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 99
Outsourcing cytological samples to a referral laboratory for EGFR testing in non-small cell lung cancer: does theory meet practice? 97
Evaluation of KRAS, NRAS and BRAF mutational status and microsatellite instability in early colorectal carcinomas invading the submucosa (pT1): Towards an in-house molecular prognostication for pathologists? 97
Molecular Testing of Thyroid Fine-Needle Aspiration: Local Issues and Solutions. An Interventional Cytopathologist Perspective 94
SIMULTANEOUS VULVAR AND PARENCHIMAL BRAIN LANGERHANS CELL HISTIOCYTOSIS: ASSOCIATION OR COINCIDENCE? 93
Cytopathology Practice in the COVID-19 Era: Focus on Sample Workload 91
Epidermal Growth Factor Receptor Test Performed on Liquid-Based Cytology Lung Samples: Experience of an Academic Referral Center. 86
Critical aspects of MSI testing in endometrial cancer: a comparison study 85
Clear Cell Neoplasm in Salivary Gland FNA? Maybe It’s From Kidney! 80
Evaluation of a New Ethanol-Based Preservative Medium for Liquid-Based Cervical Cytology: A Performance Pilot Study for Molecular Applications 76
Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective 73
Nanoscale Prognosis of Colorectal Cancer Metastasis from AFM Image Processing of Histological Sections 67
The development of a narrow target gene panel makes next generation sequencing effective for circulating free DNA analysis 66
Molecular predictive testing in precision oncology: The Italian experience 60
The relevance of the reference range for EGFR testing in non-small cell lung cancer patients 57
Understanding EGFR heterogeneity in lung cancer 53
Liquid biopsy for lung cancer: A cross section on the diagnostic routine experience of a referral Italian institution 45
Exploring genomic analysis and methylome profiling in longitudinal series of p.G12C KRAS mutated NSCLC patients treated with sotorasib 31
Analytical reliability of cell-free DNA from fine-needle aspiration rinses for BRAF and NRAS testing in metastatic melanoma 27
ERBB2 Mutation Testing in NSCLC: A Pan-European Real-World Evaluation of the Oncomine Precision Assay 20
Next-generation sequencing using a targeted gene panel in advanced solid tumors: five years of experience from an Italian referral institution 10
Technical feasibility of a long read, fourth generation sequencing platform in diagnostic profiling of clinical routine samples: a proof-of-concept study 3
Totale 8.660
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.414
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.414
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022359 9 4 5 9 5 3 4 32 30 38 91 129
2022/2023575 58 37 25 51 71 69 0 70 106 41 31 16
2023/2024332 26 69 31 17 12 9 16 56 11 3 55 27
2024/20252.282 84 139 11 11 67 97 212 140 124 304 897 196
2025/20264.621 444 331 454 369 738 183 650 239 561 312 171 169
2026/202746 46 0 0 0 0 0 0 0 0 0 0 0
Totale 8.660